Gynaecological Oncology

At IASO Thessalias, specialised services are provided for the diagnosis, treatment and follow-up of gynaecological malignancies, with an individualised approach based on current international clinical guidelines.

The management of gynaecological cancers involves collaboration among physicians from different medical specialties, with the aim of developing an appropriate treatment plan based on the diagnosis, stage of the disease and individual needs of each patient.

Services include:

• Detailed information and medical counselling regarding the disease and available treatment options.
• Surgical management of gynaecological malignancies by a specialist in Gynaecological Oncology.
• Multidisciplinary case assessment by the Gynaecological Oncology Tumour Board to support treatment planning and follow-up.
• Collaboration with the Radiation Oncology services and the Breast Centre of IASO Thessalias.
• Access to systemic treatments, where clinically indicated, through Medical Oncology services, including chemotherapy, immunotherapy and targeted therapies.
• Diagnostic investigations and imaging examinations using modern medical technology.
• Nursing care and support throughout treatment.

Surgical Management

Depending on the clinical indications and individual characteristics of each case, surgical techniques may be used to treat gynaecological malignancies, including:

• Cytoreductive surgery for advanced ovarian cancer and peritoneal disease.
• Minimally invasive techniques, including laparoscopic and robotic surgery, for the surgical staging and treatment of selected cases of endometrial and cervical cancer.
• Sentinel lymph node mapping and biopsy in selected cases of endometrial, cervical and vulvar cancer.
• Fertility-sparing surgical approaches, where oncologically appropriate.
• Complex surgical procedures performed in collaboration with other medical specialties, including General Surgery, Urology, Vascular Surgery and Thoracic Surgery.

Regular case assessment by the multidisciplinary Tumour Board supports coordinated treatment planning and subsequent follow-up, taking into account each patient's individual clinical characteristics.